Literature DB >> 2940251

A lymphoma plasma membrane-associated protein with ankyrin-like properties.

L Y Bourguignon, G Walker, S J Suchard, K Balazovich.   

Abstract

In this study we have used several complementary techniques to isolate and characterize a 72-kD polypeptide that is tightly associated with a major mouse T-lymphoma membrane glycoprotein, gp 85 (a wheat germ agglutinin-binding protein), in a 16 S complex. These two proteins do not separate in the presence of high salt but can be dissociated by treatment with 2 M urea. Further analysis indicates that the 72-kD protein has ankyrin-like properties based on the following criteria: (a) it cross-reacts with specific antibodies raised against erythrocyte and brain ankyrin; (b) it displays a peptide mapping pattern and a pI (between 6.5 and 6.8) similar to that of the 72-kD proteolytic fragment of erythrocyte ankyrin; (c) it competes with erythrocyte ghost membranes (spectrin-depleted preparations) for spectrin binding; and (d) it binds to purified spectrin and fodrin molecules. Most importantly, in intact lymphoma cells this ankyrin-like protein is localized directly underneath the plasma membrane and is found to be preferentially accumulated beneath receptor cap structures as well as associated with a membrane-cytoskeleton complex preparation. It is proposed that the ankyrin-like 72-kD protein may play an important role in linking certain surface glycoprotein(s) to fodrin which, in turn, binds to actin filaments required for lymphocyte cap formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940251      PMCID: PMC2114262          DOI: 10.1083/jcb.102.6.2115

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  36 in total

1.  Identification of immunoreactive forms of human erythrocyte band 3 in nonerythroid cells.

Authors:  D Drenckhahn; K Zinke; U Schauer; K C Appell; P S Low
Journal:  Eur J Cell Biol       Date:  1984-05       Impact factor: 4.492

2.  The structural basis of ankyrin function. I. Identification of two structural domains.

Authors:  D C Weaver; V T Marchesi
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

3.  The structural basis of ankyrin function. II. Identification of two functional domains.

Authors:  D C Weaver; G R Pasternack; V T Marchesi
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

4.  Redistribution of fodrin (a component of the cortical cytoplasm) accompanying capping of cell surface molecules.

Authors:  J Levine; M Willard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

Review 5.  Membrane-cytoskeleton interaction.

Authors:  B Geiger
Journal:  Biochim Biophys Acta       Date:  1983-08-11

Review 6.  Capping and the cytoskeleton.

Authors:  L Y Bourguignon; G J Bourguignon
Journal:  Int Rev Cytol       Date:  1984

7.  A comparative study of spectrin: a protein isolated from red blood cell membranes.

Authors:  T W Tillack; S L Marchesi; V T Marchesi; E Steers
Journal:  Biochim Biophys Acta       Date:  1970-01-20

8.  A structural model of human erythrocyte band 2.1: alignment of chemical and functional domains.

Authors:  R Wallin; E N Culp; D B Coleman; S R Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Association of myosin light chain kinase with lymphocyte membrane-cytoskeleton complex.

Authors:  L Y Bourguignon; M L Nagpal; K Balazovich; V Guerriero; A R Means
Journal:  J Cell Biol       Date:  1982-12       Impact factor: 10.539

10.  A T-lymphoma transmembrane glycoprotein (gp180) is linked to the cytoskeletal protein, fodrin.

Authors:  L Y Bourguignon; S J Suchard; M L Nagpal; J R Glenney
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  14 in total

1.  A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin.

Authors:  L Y Bourguignon; V B Lokeshwar; J He; X Chen; G J Bourguignon
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Immunoreactive analogues of erythrocyte ankyrin in human epidermal keratinocytes.

Authors:  T Shimizu; Y Takakuwa; H Koizumi; T Ishibashi; A Ohkawara
Journal:  Arch Dermatol Res       Date:  1996       Impact factor: 3.017

Review 3.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

4.  Insulin-induced myosin light-chain phosphorylation during receptor capping in IM-9 human B-lymphoblasts.

Authors:  M H Majercik; L Y Bourguignon
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

5.  Identification of a small cytoplasmic ankyrin (AnkG119) in the kidney and muscle that binds beta I sigma spectrin and associates with the Golgi apparatus.

Authors:  P Devarajan; P R Stabach; A S Mann; T Ardito; M Kashgarian; J S Morrow
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

6.  Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin.

Authors:  E L Kalomiris; L Y Bourguignon
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

7.  Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.

Authors:  L Y Bourguignon; H Zhu; L Shao; Y W Chen
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

8.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.

Authors:  S Tsukita; K Oishi; N Sato; J Sagara; A Kawai; S Tsukita
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

9.  Lymphoma Thy-1 glycoprotein is linked to the cytoskeleton via a 4.1-like protein.

Authors:  L Y Bourguignon; S J Suchard; E L Kalomiris
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  Dynamic properties of ankyrin in T lymphocytes: colocalization with spectrin and protein kinase C beta.

Authors:  C C Gregorio; E A Repasky; V M Fowler; J D Black
Journal:  J Cell Biol       Date:  1994-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.